Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR PlatformBusiness Wire • 09/04/25
Tempus to Participate in Morgan Stanley's 23rd Annual Global Healthcare ConferenceBusiness Wire • 09/03/25
4 Medical Devices Behemoths to Buy Amid Extensive AI ApplicationsZacks Investment Research • 08/22/25
TEMPUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Tempus AI, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmGlobeNewsWire • 08/14/25
Cathie Wood's Top 10 Stock Picks: Unpacking Ark Funds Innovation Picks For The Next DecadeBenzinga • 08/14/25
Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold?Zacks Investment Research • 08/13/25
TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move?Zacks Investment Research • 08/13/25
TEM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitGlobeNewsWire • 08/12/25
TEM Investors Have Opportunity to Join Tempus AI, Inc. Fraud Investigation with the Schall Law FirmPRNewsWire • 08/12/25
TEM Securities Lawsuit Filed Against Tempus AI, Inc. Contact the DJS Law Group to Discuss Your RightsPRNewsWire • 08/12/25
TEMPUS FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Tempus Investors of the August 11th Deadline and Urges Investors to Contact the FirmGlobeNewsWire • 08/11/25
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Tempus AI, Inc. of Class Action Lawsuit and Upcoming Deadlines - TEMPRNewsWire • 08/11/25
INVESTOR DEADLINE TOMORROW: Robbins Geller Rudman & Dowd LLP Announces that Tempus AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TEMPRNewsWire • 08/11/25